• 66°

Guest Opinion: New Medicare plan helps make insulin affordable at last

By Kevin Kimble

The Centers for Medicare and Medicaid Services just took a major step towards improving affordability for seniors with diabetes.

Thanks to a newly announced plan, more than 1,750 health plans will soon cap out-of-pocket costs for insulin at just $35 a month.

This action deserves praise – by lowering out-of-pocket costs, the administration can ensure that the most vulnerable Americans have access to the lifesaving drug. Let’s hope this is just the first of many likeminded reforms on the horizon.

In the midst of COVID-19 outbreak, it’s more important than ever for Americans to stay on top of their health. For those suffering from diabetes, this can prove challenging.

At particular risk are the elderly and communities of color. While roughly one in three Medicare beneficiaries has diabetes, rates run higher among African Americans and Hispanics. Compared to non-Hispanic whites, Hispanics are 66 percent more likely to develop Type 2 diabetes. For African Americans, that number is approximately 77 percent.

More than 3 million of these diabetes patients require insulin treatments to manage blood sugar levels. Failure to manage the condition can lead to catastrophic health outcomes.

Unfortunately, patients battling diabetes often face difficulty accessing medication due to cost. More than 25 percent of patients who had been prescribed insulin said they had either not filled their prescriptions, skimped on doses, or stopped use altogether because of cost, according to the Journal of the American Medical Association.

Medicare Part D has evolved over time and unfortunately, more costs have been shifted to beneficiaries. In order to fix it, the drug pricing system will require fundamental change.

Under Medicare’s prescription drug coverage – Part D – patients choose from competing plans that offer different benefits, including coverage for various prescription medications.

In exchange for coverage of their drug on a plan’s formulary, manufacturers typically offer significant discounts and rebates. In 2018 alone, they doled out $166 billion in rebates. These rebates reduce a drug’s list price 30 percent, on average.

But patients often never see a dime of these savings when purchasing medication at the pharmacy. Insurers use these savings to lower monthly plan premiums for all beneficiaries by a few dollars.

Lower premiums are welcome, of course. But they do nothing to reduce the burden of high out-of-pocket costs – especially for patients who rely on multiple medications. Since the discounts are kept secret, insurers still peg patients’ copays or coinsurance fees to the list price of the drug — not the post-rebate price.

These costs add up and net insurers billions that should instead be put towards reducing patients’ direct, out-of-pocket pharmacy costs.

Under the new program, Americans in participating Part D plans will only responsible for a flat co-pay of $35 per month for their insulin needs. That will save each beneficiary an average of $446 a year.

For many, particularly low-income members of America’s communities of color, these savings will represent a massive financial lifeline. But this is still just one step toward broader prescription drug affordability. Reducing patients’ out-of-pocket spending – for insulin and other critical medicines – requires policymakers to shed sunlight on the opaque practices of insurers.

Make no mistake – this a good first step. But it’s important that our leaders build on this momentum, and embrace fundamental changes to the drug supply chain that will lower out-of-pocket costs for all Americans.

Kevin Kimble is a member of the Health Equity Collaborative.

FOR MORE COLUMNS AND LETTERS TO THE EDITOR, CHECK OUT OUR OPINION SECTION HERE.

News

NCDOT expects parts of NC 12 to remain closed through Tuesday afternoon

News

North Carolina’s unemployment rate falls to nearly half of lockdown’s peak

Crime

Arrest made in Saturday shooting on Knotts Island

News

NC 12 on Hatteras Island to reopen at 5 p.m., NCDOT advises ‘extreme caution’

News

NC 12 on Ocracoke back open, ferry service resumes

News

Overwash causes closure of parts of NC 12 on Hatteras and Ocracoke

News

Running out of storm names, Atlantic season goes Greek

News

Regional COVID-19 case count update

News

Permit for water treatment system issued for Chemours site

News

Duck Town Council reviews promotions and contracts

News

Mascot name change presentation brought to Dare Board of Education

News

Dare County warns about coastal flooding and NC 12 impact

News

Cape Hatteras Electric Cooperative linemen travel to Alabama to assist with Hurricane Sally damage

Crime

UPDATED: Body found in Virginia believed to be missing North Carolina man, suspect charged

Hyde

NCDOT: Bigfoot Slough dredging tentatively scheduled for next week

News

Cooper: North Carolina can elementary schools move to Plan A in October

News

ARHS reports additional COVID-19 related death in Bertie County

News

Unsettled weather visits Outer Banks

News

Four positive COVID-19 cases reported at Peak Resources

News

Additional COVID-19 related death reported in Pasquotank County

News

NC lieutenant governor: Reopen schools without mask mandate

News

Some North Carolina voters mistakenly get two absentee ballots

Currituck

Currituck County Board of Education names Lutz as superintendent

Lifestyles

Constitution Week begins Thursday